MICROVIABLE
THERAPEUTICS

The human microbiota contains trillions of bacteria that play a key role in human health synthesizing essential compounds, modulating the immune response and providing protection against pathogens.

Microviable Therapeutics is a biotech company developing next generation biotherapeutic products based on human commensal bacteria to improve life quality.

OUR TEAM

We have assembled a solid and experienced team with scientific leaders in the microbiome and probiotics field to develop novel class products.

Claudio Hidalgo Cantabrana, PhD

Chief Executive Officer and co-founder

Rafael M. Permuy, MBA

Chief Business Officer and co-founder

Noelia Martínez, PhD

R&D director and co-founder

Abelardo Margolles, PhD

Scientific Advisor and co-founder
Professor of Research at IPLA-CSIC

Susana Delgado, PhD

Scientific Advisor and co-founder
Principal Investigator at IPLA-CSIC

Borja Sánchez, PhD

Scientific Advisor and co-founder
Principal Investigator at IPLA-CSIC

Claudio Hidalgo Cantabrana, PhD

Chief Executive Officer and co-founder

Rafael M. Permuy, MBA

Chief Business Officer and co-founder

Noelia Martínez, PhD

R&D director and co-founder

Rosa del Campo, PhD, MD

Scientific Advisor
Microbiologist at Hospital Ramón y Cajal, Madrid, Spain

Carlos López Otín, PhD, MD

Scientific Advisor
Professor at University of Oviedo, Spain

Josbert J. Keller, MD, PhD

Scientific Advisor
Gastroenterologist at Haaglanden Medical Center
The Hague, Netherlands.

Claudio Hidalgo Cantabrana, PhD

Chief Executive Officer and co-founder

Rafael M. Permuy, MBA

Chief Business Officer and co-founder

Noelia Martínez, PhD

R&D Director and co-founder

Desirée Barrientos

Research Assistant

Ignacio Alberti

Sales & Business Development

Ignacio Montero, PhD

Computational Biologist

Manuel Arenal, MBA

Accounting and administration

Ana Sañudo Otero, PhD

Research Scientist

Marta Fernández Gosende, MS

Research Intern

Pilar Manrique Ronquillo, PhD

Research Scientist

INVESTORS

We are thankful and grateful to the investors PadeInvest 2016 Investments SL, Inmunomet Intolerancias y Disbiosis SL and the business angels for their support.

SUBSIDIZED PROJECT

                   

MICROVIABLE THERAPEUTICS

CONTACT US

CONTACT